An expert panel convened by the FDA has issued caution in the use of drug-eluting or drug-coated stents, indicating that both physicians and patients be fully informed of the risks associated with their use. See the New York Times article "Panel Urges Caution on Coated Stents" for additional information.
Also, see the Duke Med News article "Drug-Coated Stent Patients at Risk if Anti-Blood-Clotting Medication Discontinued" for an excellent description of the rather complex issues on the use of drug-eluting stents and why more research is needed.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment